IRONWOOD PHARMACEUTICALS INC (IRWD) Stock News
NASDAQ:IRWD - Nasdaq - US46333X1081 - Common Stock - Currency: USD
IRWD Latest News, Press Relases and Analysis
IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates
Ironwood incurs a wider-than-expected loss in the first quarter of 2025. Revenues plunge year over year. Shares fall.
Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call
The drugmaker’s first-quarter revenue of $41.1 million came in well below the consensus estimate of $56.7 million, attributed to changes in AbbVie’s gross-to-net rebate reserves.
Is Johnson & Johnson (JNJ) the Best Dow Stock?
We recently published a list of The Best and Worst Dow Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other Dow stocks. The Dow Jones Industrial Average is a benchmark index of the top 30 companies in the US. It represents the strength of […]
Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates
Ironwood (IRWD) delivered earnings and revenue surprises of -180% and 21.83%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: CRON
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
Take-Two price target lowered to $236 from $240 at BMO Capital
BMO Capital lowered the firm’s price target on Take-Two (TTWO) to $236 from $240 and keeps an Outperform rating on the shares. The firm is updating its model after the company announced that its GTA VI release is pushed back to May of 2026 from the expected fall of 2025, the analyst tells investors in a research note. Investors should use the GTA VI delay-related pullback to add to positions however, the firm added. Published first on TheFly – the ultimate source for real-time, market-moving bre
Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Vivos Therapeutics (VVOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: VVOS
Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for
Ironwood (IRWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?
We recently published a list of 10 Dirt Cheap Stocks To Invest In Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other dirt cheap stocks to invest in now. Investor’s Guide to Navigating the Volatilitc The stock market has been experiencing volatility and has […]
Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News
BMY and VERV are in the spotlight this week following the failure of a late-stage study and positive cholesterol study data, respectively.
J&J projects $400m tariff hit but raises sales outlook
J&J is projecting a $400m hit due to US tariffs in 2025, but reaffirmed its profit outlook while raising its sales forecast.
J&J sees tariff impact from exports to China more than global imports: CFO
J&J faces several headwinds at the start of the year, including patent expiry, talc litigation, and, now, tariffs.
Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide
Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday?
We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) stands against other stocks that fall behind amid market optimism. Wall Street’s main indices rebounded from hefty losses on Wednesday after President Donald Trump announced that […]
Why Aglion Health Inc. (AGL) Surged On Tuesday?
We recently published a list of 10 Stocks Lead Rally Amid Market Bloodbath. In this article, we are going to take a look at where Aglion Health Inc. (NYSE:AGL) stands against other stocks that lead rally amid market bloodbath. The stock market took a battering anew on Tuesday, with all major indices registering steep losses […]
Coinbase Shares Head for Worst Quarter Since FTX Collapse as Crypto Slumps
(Bloomberg) -- Shares of Coinbase Global Inc. and other firms linked to cryptocurrencies were hammered this quarter as growing concerns about the US economy weighed on digital assets. Most Read from BloombergGold-Rush Fever Returns to Historic New Zealand Mining TownWhat Frank Lloyd Wright Learned From the DesertBank Regulators Fight for Desks as OCC Returns to New York TowerCoinbase fell 31% in the worst quarterly performance since FTX collapsed near the end of 2022. Nearly every major crypto-l
Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future
Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
